Role of Reverse Transcriptase Inhibitors in the Treatment of Psoriasis
Status:
Recruiting
Trial end date:
2022-12-15
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that the inhibition of endogenous reverse transcriptase would:
(1) reduce excess cytosolic DNA, stress initiating the inflammatory loop at the origin of
psoriatic lesions, and (2) interrupt the loop and lighten lesions